Mutations in p53 as potential molecular markers for human breast cancer
Journal Article
·
· Proceedings of the National Academy of Sciences of the United States of America; (United States)
- Salk Inst. for Biological Studies, La Jolla, CA (United States)
Based on the high incidence of loss of heterozygosity for loci on chromosome 17p in the vicinity of the p53 locus in human breast tumors. The authors investigated the frequency and effects of mutations in the p53 tumor suppressor gene in mammary neoplasia. They examined the p53 gene in 20 breast cancer cell lines and 59 primary breast tumors. Northern blot analysis, immunoprecipitation, and nucleotide sequencing analysis revealed aberrant mRNA expression, over-expression of protein, and point mutations in the p53 gene in 50% of the cell line tested. A multiplex PCR assay was developed to search for deletions in the p53 genomic locus. Multiplex PCR of genomic DNA showed that up to 36% of primary tumors contained aberrations in the p53 locus. Mutations in exons 5-9 of the p53 gene were found in 10 out of 59 (17%) of the primary tumors studied by single-stranded conformation polymorphism analysis. They conclude that, compared to amplification of HER2/NEU, MYC, or INT2 oncogene loci, p53 gene mutations and deletions are the most frequently observed genetic change in breast cancer related to a single gene. Correlated to disease status, p53 gene mutations could prove to be a valuable marker for diagnosis and/or prognosis of breast neoplasia.
- OSTI ID:
- 5703856
- Journal Information:
- Proceedings of the National Academy of Sciences of the United States of America; (United States), Journal Name: Proceedings of the National Academy of Sciences of the United States of America; (United States) Vol. 88:23; ISSN 0027-8424; ISSN PNASA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer
A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1
Constitutive CCND1/CDK2 Activity Substitutes for p53 Loss, or MYC or Oncogenic RAS Expression in the Transformation of Human Mammary Epithelial Cells
Journal Article
·
Wed May 01 00:00:00 EDT 1991
· Proceedings of the National Academy of Sciences of the United States of America; (United States)
·
OSTI ID:6055936
A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1
Journal Article
·
Sat Oct 01 00:00:00 EDT 1994
· American Journal of Human Genetics
·
OSTI ID:35499
Constitutive CCND1/CDK2 Activity Substitutes for p53 Loss, or MYC or Oncogenic RAS Expression in the Transformation of Human Mammary Epithelial Cells
Journal Article
·
Sun Feb 03 19:00:00 EST 2013
· PLoS ONE
·
OSTI ID:1627577
Related Subjects
550200* -- Biochemistry
59 BASIC BIOLOGICAL SCIENCES
ANIMALS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL MARKERS
BODY
CHROMOSOMES
DAYS LIVING RADIOISOTOPES
DISEASES
DNA
DNA SEQUENCING
ELECTROPHORESIS
FEMALES
GENE MUTATIONS
GENE REPRESSORS
GLANDS
HUMAN CHROMOSOME 17
HUMAN CHROMOSOMES
ISOTOPES
LIGHT NUCLEI
MAMMALS
MAMMARY GLANDS
MAN
MUTATION FREQUENCY
MUTATIONS
NEOPLASMS
NUCLEI
NUCLEIC ACIDS
NUCLEOPROTEINS
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
ORGANS
PHOSPHORUS 32
PHOSPHORUS ISOTOPES
PRIMATES
PROTEINS
RADIOISOTOPES
RECOMBINANT DNA
STRUCTURAL CHEMICAL ANALYSIS
VERTEBRATES
WOMEN
59 BASIC BIOLOGICAL SCIENCES
ANIMALS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL MARKERS
BODY
CHROMOSOMES
DAYS LIVING RADIOISOTOPES
DISEASES
DNA
DNA SEQUENCING
ELECTROPHORESIS
FEMALES
GENE MUTATIONS
GENE REPRESSORS
GLANDS
HUMAN CHROMOSOME 17
HUMAN CHROMOSOMES
ISOTOPES
LIGHT NUCLEI
MAMMALS
MAMMARY GLANDS
MAN
MUTATION FREQUENCY
MUTATIONS
NEOPLASMS
NUCLEI
NUCLEIC ACIDS
NUCLEOPROTEINS
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
ORGANS
PHOSPHORUS 32
PHOSPHORUS ISOTOPES
PRIMATES
PROTEINS
RADIOISOTOPES
RECOMBINANT DNA
STRUCTURAL CHEMICAL ANALYSIS
VERTEBRATES
WOMEN